Spirit Health said on social media that it plans to make a new continuous glucose monitor (CGM) available next month. The company designed its user-friendly CareSens Air CGM to simplify diabetes management. It plans to make the system available in the UK in February, according to a post on LinkedIn. The post reads: “Our new […]
Dexcom expects sales to grow 14% in 2025
Dexcom (Nasdaq:DXCM) today announced preliminary financial results with projections for significant sales growth in 2025. Shares of DXCM dipped 1.5% to $76.57 in mid-morning trading today. The San Diego-based continuous glucose monitor (CGM) maker reported preliminary 2024 revenues of $4.032 billion. That marks an 11% increase over 2023. For 2025, Dexcom anticipates total revenue of […]
Senseonics to consider reverse stock split, reports strong Eversense 365 interest
Senseonics (NYSE:SENS) announced preliminary financial results for 2024 as it considers a reverse stock split. Given a recent appreciation in the company’s share price, Senseonics decided not to proceed with a planned special meeting of stockholders. The company took this decision to consider the stock split. Shares of SENS rose 43% to 62¢ apiece at […]
Hedia, Glooko launch personalized bolus insulin dosing tech
Glooko and Hedia announced today that launched their interoperable solution for advanced bolus insulin dosing support. The solution combines connected care, remote patient monitoring and digital therapeutic technologies. It aims to enhance access for people with type 1 and type 2 diabetes requiring advanced bolus insulin dosing support. The companies kicked off their launch in […]
Phillips Medisize enhances inhaled drug delivery portfolio with Vectura acquisition
Phillips Medisize parent company Molex announced today that it completed its acquisition of Vectura from a subsidiary of cigarette maker Philip Morris. The company says adding Vectura enables it to offer a wider range of formulation, device design, combination product development and manufacturing services. It acquires Vectura’s proprietary technology and combination product development expertise in dry […]
Tandem inks collab with UVA to develop closed-loop automated insulin delivery tech
Tandem Diabetes Care (Nasdaq:TNDM) announced today that it signed a multi-year R&D collaboration agreement with the University of Virginia (UVA). The collaboration with the UVA Center for Diabetes Technology aims to advance R&D efforts on fully automated, closed-loop insulin delivery systems. Tandem develops its own closed-loop systems, including the t:slim X2 and Mobi pumps, which […]
CeQur raises $120M to support insulin delivery tech
CeQur announced today that it closed a $120 million financing round to support its wearable insulin delivery technology. Horw, Switzerland-based CeQur plans to use the funds to drive growth and accelerate commercial expansion efforts. It aims to scale commercial teams and outreach initiatives to bring Simplicity, its four-day wearable insulin delivery device, to more healthcare […]
Beta Bionics is proposing an IPO
Beta Bionics announced today that it filed a registration statement with the SEC relating to a proposed initial public offering (IPO). The amount of shares of common stock included in the IPO and the price range remain undetermined. Irvine, California-based Beta Bionics filed to list its common stock on the Nasdaq market under the “BBNX” […]
PreEvnt to unveil non-invasive blood glucose alert device
PreEvnt recently announced plans to introduce Isaac, its non-invasive alert device for monitoring blood glucose levels. Isaac, which is meant to monitor blood glucose levels using just the breath of the user, also has a custom phone app. It comes small enough to be worn on an included lanyard or pocket clip and reduces the […]
Abbott, Dexcom settle global CGM patent litigation
Abbott (NYSE:ABT) announced today that it reached an agreement with Dexcom (Nasdaq:DXCM) to settle all outstanding patent disputes between companies. The patent litigation relates to the companies’ continuous glucose monitor (CGM) technologies. Abbott and Dexcom are two leaders in the CGM space. They offer market-leading platforms, with Abbott’s FreeStyle Libre 3 and Dexcom’s G7 representing […]
